SCH-900105

· M.D. Anderson Cancer Center

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SCH-900105, covering 2012-02-20 to 2012-02-20. Get the full timeline:

Most recent: Clinical Trial Update: SCH-900105 in Recurrent Glioblastoma [Phase 1]